Bio-Rad Laboratories Mourns Loss of Co-Founder Alice Schwartz
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Bio-Rad Laboratories ( (BIO) ).
On September 29, 2025, Bio-Rad Laboratories announced the passing of its co-founder and Director Emeritus, Alice N. Schwartz, on September 25, 2025, at the age of 99. Alice Schwartz, who co-founded the company in 1952, played a pivotal role in its growth and success, particularly in the development of Bio-Rad’s first test kit for thyroid function, which marked the company’s entry into clinical diagnostics. Her leadership and passion for scientific discovery have left a lasting legacy at Bio-Rad and in the broader scientific community.
The most recent analyst rating on (BIO) stock is a Hold with a $288.00 price target. To see the full list of analyst forecasts on Bio-Rad Laboratories stock, see the BIO Stock Forecast page.
Spark’s Take on BIO Stock
According to Spark, TipRanks’ AI Analyst, BIO is a Neutral.
Bio-Rad Laboratories’ overall stock score is driven by its financial recovery and positive earnings call, which highlight strong performance and strategic acquisitions. However, bearish technical indicators and moderate valuation limit the score. The absence of a dividend yield and challenges in certain market segments also weigh on the overall assessment.
To see Spark’s full report on BIO stock, click here.
More about Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,500 employees, and $2.6 billion in revenues in 2024. Their customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety, and environmental quality laboratories.
Average Trading Volume: 262,593
Technical Sentiment Signal: Sell
Current Market Cap: $7.31B
For an in-depth examination of BIO stock, go to TipRanks’ Overview page.
